greeksoup/ stock research
Stock research / United States / CVS · Retail-Drug Stores And Proprietary Stores · NYSE

CVS Health Corp. (CVS)

CVS Health is a health solutions company that connects insurance, pharmacy benefits management and retail pharmacy inside one group. At 31 December 2025 it had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics and a pharmacy benefits manager with approximately 87 million plan members, and it served an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services. There are four reportable segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate/Other. The company states that its strategy is focused on simplifying health care experiences, improving engagement, lowering costs and delivering better health outcomes.

CVS Health Corp.

CVS Health is a health solutions company that connects insurance, pharmacy benefits management and retail pharmacy inside one group. At 31 December 2025 it had approximately 9,000 retail locations, more than 1,000 walk-in and primary care medical clinics and a pharmacy benefits manager with approximately 87 million plan members, and it served an estimated more than 37 million people through traditional, voluntary and consumer-directed health insurance products and related services. There are four reportable segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate/Other. The company states that its strategy is focused on simplifying health care experiences, improving engagement, lowering costs and delivering better health outcomes.

Health Care Benefits

The segment runs the Aetna operations and offers medical, pharmacy, dental and behavioural health plans, medical management, Medicare Advantage and Medicare Supplement plans, standalone Medicare Part D prescription drug plans and Medicaid health care management services. Members reach those products through employer groups, government-sponsored plans or individually. Products where the company takes all or most of the risk for medical and dental care costs are called Insured; those where the plan sponsor takes that risk are administrative services contracts. Commercial medical products include point-of-service, preferred provider organisation, health maintenance organisation and indemnity plans, health savings accounts, consumer-directed plans and medical stop loss cover for employers that self-insure. The filing describes the industry as highly competitive, with many for-profit and not-for-profit competitors, continual new products, new entrants and consolidation.

Health Services

The segment provides pharmacy benefits management through CVS Caremark and delivers care in medical clinics, virtually and in the home. Its work covers plan design and administration, formulary management, retail pharmacy network management, specialty and mail order pharmacy, clinical and disease management services, medical spend management and administrative services for providers and for entities covered by the federal 340B drug pricing program. It runs a group purchasing organisation that negotiates pricing and rebates with drug manufacturers, and its Cordavis subsidiary works with manufacturers on biosimilar products. Health care delivery assets include Signify Health in health risk assessments and value-based care and Oak Street Health in value-based primary care for Medicare eligible patients. During 2025 the pharmacy benefits manager filled or managed 1.9 billion prescriptions on a 30-day equivalent basis.

Pharmacy and Consumer Wellness

The segment dispenses prescriptions in CVS Pharmacy retail locations and through infusion operations, runs patient care programmes and vaccination administration, and sells health and wellness products and general merchandise. It also handles fulfilment for the specialty and mail order pharmacy offerings of Health Services. Alongside the retail locations it operates online pharmacy websites, retail specialty pharmacy stores, compounding pharmacies and branches for infusion and enteral nutrition. During 2025 it filled 1.8 billion prescriptions on a 30-day equivalent basis and dispensed approximately 28.5% of total retail pharmacy prescriptions in the United States. Front store categories cover over-the-counter drugs, consumer health, beauty, personal care and other general merchandise. The filing states that competition here runs mainly on store location and convenience, customer service, product selection and price, against drugstore chains, supermarkets, discount retailers, independent pharmacies, online retailers, membership clubs and mail order pharmacies.

Corporate and sourcing

Corporate/Other holds management and administrative costs supporting the whole group, including executive management, corporate relations, legal, compliance, human resources, finance, information technology, digital, data and analytics, together with acquisition-related transaction and integration costs, and it also holds products no longer sold to new customers such as large case pensions and long-term care insurance. Generic drug sourcing runs through Red Oak Sourcing, a venture owned half by the company and half by Cardinal Health, which negotiates generic supply contracts for both owners and holds no inventory itself. The company states that its workforce numbers more than 300,000 colleagues.

From CVS Health's annual report on Form 10-K for the year ended 31 December 2025. The filing

Compare with another name What $10,000 in CVS Health became

Latest results

Latest quarterQ3 FY2026ended 30 September 2026 · 10-Q filed 4 November 2026
Revenue
$108.4 billion
+5.4% on the year · +2.2% on the quarter
Q4 FY2024Q3 FY2026
Net income
$2.2 billion
-27.1% on the quarter
Q4 FY2024Q3 FY2026
Diluted EPS
$1.68
-27.3% on the quarter
Q4 FY2024Q3 FY2026

this quarterthe same quarter a year earlierHover a bar for its figure.

Read the Q3 FY2026 results →the 10-Q on EDGAR ↗
Last full yearFY2025ended 31 December 2025 · 10-K filed 10 February 2026
Revenue
$402.1 billion
+7.8% on the year
FY2018FY2025
Net income
$1.8 billion
-61.7% on the year
FY2018FY2025
Diluted EPS
$1.39
-62.0% on the year
FY2018FY2025

this yearthe year beforeHover a bar for its figure.

The years before, in wordsCVS Health (CVS) reported revenue of $402.1 billion for fiscal 2025, the year ended 31 December 2025, up 7.8% on the year before. Net income was $1.8 billion and diluted earnings per share $1.39. Revenue was $372.8 billion in fiscal 2024, $357.8 billion in fiscal 2023, $322.5 billion in fiscal 2022 and $292.1 billion in fiscal 2021. Net income in the same years was $4.6 billion, $8.3 billion, $4.3 billion and $8.0 billion. Over the twelve months to 30 September 2026, CVS Health reported revenue of $420.6 billion and net income of $11.0 billion. Revenue grew 8.4% a year, compounded, over the five years to fiscal 2025. CVS Health declared $2.66 a share in dividends over the last four quarters and had 1.28 billion shares outstanding at the latest filed count. At 30 September 2026 it carried $60.7 billion of debt and $11.7 billion of cash. At the close of 6 November 2026 the market cap of CVS Health was $107.3 billion, 9.8 times its earnings over the last twelve months.
Read the FY2025 results →the 10-K on EDGAR ↗

Ratios

From the filings

ROE13.7%
ROCE10.7%
Operating margin3.6%
Net margin2.6%
FCF margin3.7%
Interest cover4.9x
Debt to equity0.75x
Cash conversion1.70x
Share count, last 12 months0.8%
Sales CAGR, 3 years7.6%
Profit CAGR, 3 years-25.7%
EPS, TTM$8.59

At the close of 6 November 2026

Price$83.84
Market cap$107.3 billion
Stock P/E9.8x
Price to book1.3x
EV / EBITDA8.0x
Dividend yield3.2%
Market cap / sales0.26x
52-week high$110.60
52-week low$70.08
Price, 1 year6.6%
Price CAGR, 3 years6.1%
Price CAGR, 5 years-2.2%

29 ready-made ratios, from FCF yield to net debt to EBITDA, wait on the Formulas page, each with what it tells you. Browse and add them →

Worked from the filed figures; hover a name for the formula.
Read moreThe priced ones use the latest price, the last regular-hours trade on IEX. Debt to equity here stands on the borrowing lines of CVS Health Corp.'s balance sheet, added together, finance leases inside them only where the company puts them there; operating leases are a separate line. Nothing here is a valuation or a view.
CVSgreeksoup.ai
Daily prices to 6 November 2026, adjusted for splits; from 28 September 2026 each day's price is the last regular-hours trade on IEX.
Read moreData provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use. Day by day for the last three years; before that one point a week, carrying the week's last close and its average daily volume, so a volume bar means the same thing across the whole series; the bars sit under the price on their own scale, on the right. The moving averages need consecutive days and are drawn from the daily part. P/E is the close over the trailing four quarters' EPS as filed at each filing date, on the current share count; the dashed line is the median over the range shown. Sales and margin are quarterly revenue and the operating margin from the tables above. EV/EBITDA, price to book and market cap to sales use the latest filed balance sheet and share count at each date. Before the quarters on file begin, P/E, price to book and market cap to sales stand on each annual report from the day it was filed. Drawn in your browser; the range and overlay you pick are remembered here only.

Quarterly results

Q4 FY2021 *Q1 FY2022 †Q2 FY2022 †Q3 FY2022 †Q4 FY2022 * †Q1 FY2023Q2 FY2023Q3 FY2023Q4 FY2023 *Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024 *Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025 *Q1 FY2026Q2 FY2026Q3 FY2026
Revenue76,60476,82680,63681,15983,84685,27888,92189,76493,81388,43791,23495,42897,71094,58898,915102,871105,693100,426106,096108,399
Cost of revenue46,37845,50949,29050,36551,72851,45553,53654,68857,41948,07349,99852,94855,26851,05754,00557,04559,06055,44458,86261,185
Gross profit30,22631,31731,34630,79432,11833,82335,38535,07636,39440,36441,23642,48042,44243,53144,91045,82646,63344,98247,23447,214
Gross margin39%41%39%38%38%40%40%39%39%46%45%45%43%46%45%45%44%45%45%44%
Operating income2,2293,5454,669-3,9193,6593,4463,2343,6903,3732,2713,0458322,3683,3742,381-3,2072,1124,6804,7033,566
Operating margin3%5%6%-5%4%4%4%4%4%3%3%1%2%4%2%-3%2%5%4%3%
Interest expense608586583566552589686693690716732752758785763784787774757747
Pre-tax income1,5703,0014,129-4,4443,1502,8792,5703,0192,7051,5802,3371052,1262,6171,647-3,4821,3543,9383,9772,849
Tax rate17%22%26%n/a26%26%26%25%24%29%24%32%24%32%38%n/a-116%25%25%24%
Net income1,3062,3543,029-3,4062,3342,1361,9012,2612,0461,1131,77087.01,6441,7791,021-3,9752,9432,9432,9792,172
Net margin2%3%4%-4%3%3%2%3%2%1%2%0%2%2%1%-4%3%3%3%2%
Diluted EPS$0.97$1.77$2.29-$2.59$1.77$1.65$1.48$1.75$1.58$0.88$1.41$0.07$1.30$1.41$0.80-$3.13$2.30$2.30$2.31$1.68
Operating cash flow4,0053,5635,4439,123-1,9527,4385,9082,716-2,6364,9033,089-7451,8604,5561,8977963,3904,2496,3454,724
Capital expenditure5971,051408580688984591545911705638670768743607698784849691817
Free cash flow3,4082,5125,0358,543-2,6406,4545,3172,171-3,5474,1982,451-1,4151,0923,8131,29098.02,6063,4005,6543,907
Buybacks0.02,0000.00.01,5002,018-2.0-3.0-1.03,027-3.0-1.00.00.00.00.00.0n/an/an/a
Dividends paid660722740726719779795779779840858837838840866846845847878853
Shares outstanding1,322m1,306m1,312m1,315m1,300m1,279m1,282m1,287m1,288m1,252m1,256m1,258m1,260m1,262m1,267m1,270m1,271m1,273m1,278m1,280m
Filing10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q10-K10-Q10-Q10-Q
Each quarter as filed, linked to its filing.
Read more* The fourth quarter is the full year less the first three quarters, because the company files the year and not the quarter on its own. A fourth quarter's EPS, and its diluted share count where shown, are from the company's results press release for that quarter, checked against the company's filed figures or a second data source. A quarter marked † is shown as the company last restated it in a later filing, so it compares with the quarters around it on one basis; rest on a figure for the one first filed. EPS is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and the share count are as they are. Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Cash flow lines filed year to date are the difference between two filings. Shares outstanding are at the period end where the balance sheet tags them, otherwise the count on the filing's cover page. A derived fourth-quarter EPS is left blank when a split in the year makes the arithmetic meaningless.

Income statement (profit and loss)

FY2007FY2008 †FY2009 †FY2010 †FY2011 †FY2012 †FY2013FY2014FY2015 †FY2016 †FY2017 †FY2018FY2019 †FY2020 †FY2021 †FY2022 †FY2023FY2024FY2025TTM
Revenue76,33087,47298,21595,778107,100123,133126,761139,367153,290177,526184,765194,579256,776268,706292,111322,467357,776372,809402,067420,614
Cost of revenue60,22269,18277,85775,55986,539100,627102,978114,000126,762148,669156,220156,447158,719163,981175,803196,892217,098206,287221,167234,551
Gross profit16,10818,29020,38020,25720,56122,50623,78325,36726,52828,85728,54538,13298,057104,725116,308125,575140,678166,522180,900186,063
Gross margin21.1%20.9%20.8%21.1%19.2%18.3%18.8%18.2%17.3%16.3%15.4%19.6%38.2%39.0%39.8%38.9%39.3%44.7%45.0%44.2%
Operating income4,7946,0466,4256,1376,3307,2108,0378,7999,47510,3869,5384,02111,98713,91113,3107,95413,7438,5164,66015,061
Operating margin6.3%6.9%6.5%6.4%5.9%5.9%6.3%6.3%6.2%5.9%5.2%2.1%4.7%5.2%4.6%2.5%3.8%2.3%1.2%3.6%
Interest expensen/a5305305395885615176158591,0781,0622,6193,0352,9072,5032,2872,6582,9583,1193,065
Pre-tax income4,3595,5375,9005,6015,7466,3057,5287,6788,6168,6378,2681,4068,9979,77010,5375,83611,1736,1482,13612,118
Income tax1,7222,1932,2002,1792,2582,4362,9283,0333,3863,3171,6372,0022,3662,5692,5481,5092,8051,5624081,072
Effective tax rate39.5%39.6%37.3%38.9%39.3%38.6%38.9%39.5%39.3%38.4%19.8%142.4%26.3%26.3%24.2%25.9%25.1%25.4%19.1%8.8%
Net income2,6373,1983,6963,4273,4613,8644,5924,6445,2375,3176,622-5946,6347,1798,0014,3118,3444,6141,76811,037
Net margin3.5%3.7%3.8%3.6%3.2%3.1%3.6%3.3%3.4%3.0%3.6%-0.3%2.6%2.7%2.7%1.3%2.3%1.2%0.4%2.6%
Diluted EPS$1.92$2.18$2.55$2.49$2.57$3.03$3.74$3.96$4.63$4.90$6.44-$0.57$5.08$5.46$6.02$3.26$6.47$3.66$1.39$8.59
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K8-K8-K10-K10-K10-K
From each year's 10-K, linked; TTM is the last four quarters.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are. † The year as the company last restated it in a later filing; rest on a figure for the one first filed. EPS is as filed.

Cash flow

FY2007FY2008 †FY2009 †FY2010 †FY2011 †FY2012 †FY2013FY2014FY2015 †FY2016 †FY2017 †FY2018FY2019 †FY2020 †FY2021 †FY2022 †FY2023FY2024FY2025TTM
Operating cash flow3,2303,9474,0354,7795,8566,6715,7838,1378,53910,1418,0078,86512,84815,86518,26516,17713,4269,10710,63918,708
Capital expenditure1,8052,1802,5482,0051,8722,0301,9842,1362,3672,2241,9182,0372,4572,4372,5202,7273,0312,7812,8323,141
Free cash flow1,4251,7671,4872,7743,9844,6413,7996,0016,1727,9176,0896,82810,39113,42815,74513,45010,3956,3267,80715,567
Free cash flow margin1.9%2.0%1.5%2.9%3.7%3.8%3.0%4.3%4.0%4.5%3.3%3.5%4.0%5.0%5.4%4.2%2.9%1.7%1.9%3.7%
Cash from investing-3,082-4,580-1,069-1,640-2,410-1,849-1,835-4,045-13,420-2,470-2,877-43,285-3,339-5,534-5,261-5,047-20,889-7,613-5,871-7,543
Cash from financing378929-3,232-2,798-3,460-4,860-1,237-5,6944,879-6,761-6,75136,819-7,654-7,696-11,356-10,5162,683-1,135-4,940-8,569
Depreciation and amortisation1,0951,2741,3891,4691,5681,7531,8701,9312,0922,4752,4792,7184,3714,4414,4864,2244,3664,5974,6064,520
Share-based compensation78.092.0165150135132141165230222234280453400484447588540535745
Buybacks5,37023.02,4771,5003,0014,3303,9764,0015,0014,4614,3610.00.00.00.03,5002,0123,0230.0n/a
Dividends paid3233834394796748291,0971,2881,5761,8402,0492,0382,6032,6242,6252,9073,1323,3733,3973,423
Dividend per share$0.23$0.26$0.30$0.35$0.50$0.65$0.90$1.10$1.40$1.70$2.00$2.00$2.00$2.00$2.00$2.20$2.42$2.66$2.66$2.66
Diluted shares, weighted1,372m1,469m1,450m1,377m1,347m1,280m1,226m1,169m1,126m1,079m1,024m1,044m1,305m1,314m1,329m1,323m1,290m1,262m1,271m1,291m
Shares outstanding at period endn/a1,437m1,391m1,363m1,298m1,231m1,180m1,140m1,101m1,061m1,014m1,295m1,302m1,310m1,322m1,300m1,288m1,260m1,271m1,280m
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K8-K8-K10-K10-K10-K
Cash paid in the year, from the cash flow statement.
Read moreThe dividend per share is as declared. Diluted shares are the weighted average for the year; a falling count is the buybacks net of issuance. TTM sums the last four quarters; the share counts are the latest quarter's.

Balance sheet

FY2007FY2008 †FY2009 †FY2010 †FY2011 †FY2012 †FY2013FY2014FY2015 †FY2016 †FY2017 †FY2018FY2019 †FY2020 †FY2021 †FY2022 †FY2023FY2024FY2025TTM
Funded by
Shareholders' equity31,32234,57435,76837,70038,05137,65337,93837,95837,19636,83037,69158,22563,86469,38974,53571,46976,46175,56075,21480,497
Non-controlling interestn/an/an/an/an/a51.00.05.07.04.04.0318306312306300175170168192
Redeemable equityn/an/an/an/an/an/an/a0.039.00.0n/an/an/an/an/an/an/an/an/an/a
Short-term borrowingsn/a3,044315300n/an/a0.0n/a0.0n/a1,2767200.0n/an/an/an/an/an/an/a
Debtn/a8,71011,17510,05710,0149,82813,40012,89027,50027,53127,00273,42968,48064,64756,17652,25461,61066,27064,57060,680
Operating lease liabilitiesn/an/an/an/an/an/an/an/an/an/a30626918,92618,75718,17716,80016,03414,89913,64312,697
Finance lease liabilitiesn/an/an/an/an/an/an/an/an/an/an/an/a7811,0501,2501,4061,3251,2951,265n/a
Other liabilitiesn/a14,63114,38314,11216,78718,68920,18823,39927,69530,09728,85263,49570,09276,56082,55586,04694,12395,02198,678104,009
Total liabilities and equityn/a60,96061,64162,16964,85266,22171,52674,25292,43794,46295,131196,456222,449230,715232,999228,275249,728253,215253,538258,075
Owned
Fixed assetsn/a8,1257,9238,3228,4678,6328,6158,8439,85510,17510,29211,34912,04412,60612,89612,873n/an/an/an/a
Goodwilln/a25,49425,68025,66926,45826,39526,54228,14238,10638,24938,45178,67879,74979,55279,12178,15091,27291,27285,47885,478
Intangible assetsn/a10,44610,1279,7849,8699,7539,5299,77413,87813,51113,63036,52433,12131,14229,02624,75429,23427,32325,50824,224
Investmentsn/a0.05.04.05.05.088.085.088.087.022318,25419,68723,81226,14223,87426,27831,34134,81437,215
Cash and equivalents1,0571,3521,0861,4271,4131,3754,0892,4812,4593,3711,6964,0595,6837,8549,40812,9458,1968,5868,45311,738
Receivablesn/a5,3845,4574,9256,0476,4738,7299,68711,88812,16413,18117,63119,61721,74224,43127,27635,22736,46939,77942,073
Inventoryn/a9,15310,34310,69510,04611,03211,04511,93014,00114,76015,29616,45017,51618,49617,76019,09018,02518,10719,24618,240
Other assetsn/a1,0051,0201,3432,5472,5562,8893,3102,1622,1452,36213,51135,03235,51134,21529,31341,49640,11740,26039,107
Total assetsn/a60,96061,64162,16964,85266,22171,52674,25292,43794,46295,131196,456222,449230,715232,999228,275249,728253,215253,538258,075
Filing10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K10-K8-K8-K10-K10-K10-K
At the fiscal year end; the TTM column is the latest quarter end.
Read moreBoth totals are the company's own. Other liabilities is the filed total less the rows above it: payables, deferred revenue, taxes, borrowings the rows above do not carry and the rest; other assets is the same on the other side. Investments add the current and non-current lines as filed. Debt is the company's own stated total where it files one, otherwise its long-term debt with the current maturities, never parts added together. A row is left blank in a year where the lines shown overlap and the remainder would fall below nil.

Compounded growth

10 years5 years3 yearsTTM
Sales growth, compounded10.1%8.4%7.6%6.7%
Profit growth, compounded-10.3%-24.4%-25.7%2253.3%
Return on equity, average8.8%7.2%6.5%2.4%
Yearly growth, compounded; TTM is the last four quarters against the four before.
Read moreReturn on equity is net income over shareholders' equity at each year end, averaged over the window (the TTM column is the latest year alone); equity is the parent's shareholders' equity as tagged in the 10-K. Arithmetic on filed numbers, nothing forecast.

Questions

What was CVS Health's revenue in fiscal 2025?

CVS Health (CVS) reported revenue of $402.1 billion for fiscal 2025, the year ended 31 December 2025, up 7.8% on the year before.

How much did CVS Health earn in fiscal 2025?

Net income was $1.8 billion for fiscal 2025, and diluted earnings per share $1.39.

What is CVS Health's P/E ratio?

At the close of 6 November 2026, CVS Health traded at 9.8 times its earnings over the twelve months to 30 September 2026.

What is CVS Health's market cap?

The market cap of CVS Health was $107.3 billion at the close of 6 November 2026.

Does CVS Health pay a dividend?

Yes. CVS Health declared $2.66 a share in dividends over the four quarters to 30 September 2026.

Peers: Retail

CompanyMarket capP/EROEOp. marginSales growth
TTM		Debt to equityDiv. yield
TJX Companies Inc. TJX$149.0 billion25.0157.0%n/a7.7%0.271.3%
Lowe's Companies Inc. LOW$126.0 billion18.99n/a11.4%8.2%n/a2.2%
CVS Health Corp. CVS$107.3 billion9.7613.7%3.6%6.7%0.753.2%
Sherwin Williams Co. SHW$83.1 billion31.6267.3%n/a7.0%2.970.9%
Carvana Co. CVNA$81.1 billion38.4339.2%8.7%50.3%1.20n/a
ROSS Stores, Inc. ROST$73.8 billion27.9739.4%13.7%14.0%0.150.7%
O'Reilly Automotive, Inc. ORLY$72.3 billion27.58n/a19.8%8.7%n/an/a
Target Corp. TGT$71.9 billion16.4424.6%5.6%2.0%0.862.9%
Fastenal Co. FAST$60.8 billion42.7334.2%20.5%13.5%0.021.8%
Autozone Inc. AZO$52.0 billion21.04n/a18.3%7.4%n/an/a
JD.com, Inc. JD *$40.0 billion15.038.7%0.2%13.0%0.333.6%
Guardian Pharmacy Services, Inc. GRDN$2.7 billion36.2726.7%6.5%4.9%0.00n/a
All 110 in Retail
CompanyMarket capP/EROEOp. marginSales growth
TTM		Debt to equityDiv. yield
Amazon.com Inc. AMZN$2.80 trillion20.9722.0%13.1%15.4%0.29n/a
Walmart Inc. WMT$995.5 billion45.3022.5%4.4%6.2%0.510.7%
Costco Wholesale Corp. COST$467.0 billion50.7425.8%3.9%10.1%0.170.5%
Home Depot, Inc. HD$342.7 billion24.0385.6%12.4%2.5%3.182.7%
TJX Companies Inc. TJX$149.0 billion25.0157.0%n/a7.7%0.271.3%
Lowe's Companies Inc. LOW$126.0 billion18.99n/a11.4%8.2%n/a2.2%
CVS Health Corp. CVS$107.3 billion9.7613.7%3.6%6.7%0.753.2%
Sherwin Williams Co. SHW$83.1 billion31.6267.3%n/a7.0%2.970.9%
Carvana Co. CVNA$81.1 billion38.4339.2%8.7%50.3%1.20n/a
ROSS Stores, Inc. ROST$73.8 billion27.9739.4%13.7%14.0%0.150.7%
O'Reilly Automotive, Inc. ORLY$72.3 billion27.58n/a19.8%8.7%n/an/a
Target Corp. TGT$71.9 billion16.4424.6%5.6%2.0%0.862.9%
Fastenal Co. FAST$60.8 billion42.7334.2%20.5%13.5%0.021.8%
Autozone Inc. AZO$52.0 billion21.04n/a18.3%7.4%n/an/a
JD.com, Inc. JD *$40.0 billion15.038.7%0.2%13.0%0.333.6%
Kroger Co. KR$40.0 billion36.8018.6%1.4%1.6%2.912.1%
Williams Sonoma Inc. WSM$29.9 billion26.0155.1%19.2%2.2%0.001.1%
Copart Inc. CPRT$29.6 billion20.6116.3%35.4%0.4%0.00n/a
Dollar General Corp. DG$29.5 billion17.3918.3%5.6%4.8%0.491.8%
Coupang, Inc. CPNG$29.2 billionn/a-48.0%-3.4%7.4%0.62n/a
Ulta Beauty, Inc. ULTA$27.6 billion23.4945.8%12.5%11.2%0.13n/a
Casey's General Stores, Inc. CASY$25.4 billion33.1318.9%8.3%13.8%0.590.3%
Dollar Tree, Inc. DLTR$24.6 billion16.0247.1%11.0%8.2%0.86n/a
Best Buy Co., Inc. BBY$21.0 billion16.5840.0%4.1%1.4%0.373.8%
CDW Corp. CDW$19.6 billion18.3341.7%7.0%10.9%2.701.6%
Tractor Supply Co. TSCO$18.9 billion19.5436.7%8.2%3.5%0.842.6%
Burlington Stores, Inc. BURL$15.5 billion22.1435.7%7.7%10.9%0.96n/a
Wayfair Inc. W$15.3 billionn/an/a2.1%7.9%n/an/a
Penske Automotive Group, Inc. PAG$13.9 billion15.5015.2%3.7%1.4%0.842.7%
BJ's Wholesale Club Holdings, Inc. BJ$13.8 billion23.9527.1%3.8%9.1%0.29n/a
Five Below, Inc. FIVE$13.2 billion21.5925.0%14.7%25.6%0.00n/a
Dick's Sporting Goods, Inc. DKS$12.5 billion15.1214.7%5.5%53.5%0.333.5%
GameStop Corp. GME$11.3 billion16.5214.5%13.5%-7.7%0.68n/a
Murphy USA Inc. MUSA$9.5 billion14.6183.6%4.2%20.2%2.760.5%
Chewy, Inc. CHWY$9.1 billion34.1773.9%2.5%5.9%1.60n/a
Victoria's Secret & Co. VSXY$8.6 billion24.4438.2%7.9%10.3%0.98n/a
FirstCash Holdings, Inc. FCFS$8.0 billion20.1217.9%12.9%22.9%1.080.9%
Gap Inc. GAP$7.5 billion6.4131.6%11.0%1.1%0.383.2%
Carmax Inc. KMX$7.3 billion25.124.6%n/a4.8%2.76n/a
Urban Outfitters Inc. URBN$7.3 billion13.2319.9%11.3%11.0%0.00n/a
Builders FirstSource, Inc. BLDR$6.7 billion168.971.0%2.1%-8.3%1.13n/a
Lithia Motors Inc. LAD$6.7 billion8.8811.9%4.0%1.6%1.780.8%
Abercrombie & Fitch Co. ANF$6.3 billion12.7939.6%13.7%4.7%0.00n/a
Macy's, Inc. M$6.0 billion8.4615.2%5.0%0.3%0.493.2%
Albertsons Companies, Inc. ACI$6.0 billionn/a-3.6%0.5%2.3%6.515.0%
Autonation, Inc. AN$5.9 billion8.8431.9%4.6%-1.8%3.06n/a
Floor & Decor Holdings, Inc. FND$5.4 billion22.989.6%6.5%1.8%0.08n/a
Ollie's Bargain Outlet Holdings, Inc. OLLI$5.4 billion20.1614.4%12.3%14.4%0.00n/a
Rush Enterprises Inc. RUSHA$5.1 billion19.1311.6%5.1%-2.6%0.521.2%
Pricesmart Inc. PSMT$5.0 billion30.1011.4%4.4%11.5%0.120.9%
Insight Enterprises Inc. NSIT$4.6 billion26.5711.6%4.1%9.0%0.96n/a
Sprouts Farmers Market, Inc. SFM$4.5 billion9.4232.4%7.3%5.3%0.08n/a
Signet Jewelers Ltd. SIG$4.5 billion13.5119.3%6.8%0.6%0.001.1%
Bath & Body Works, Inc. BBWI$4.3 billion5.56n/a16.7%-2.2%n/a3.7%
Openlane, Inc. OPLN$4.2 billionn/a12.5%11.9%12.8%1.65n/a
Academy Sports & Outdoors, Inc. ASO$4.2 billion11.2218.2%9.6%3.7%0.230.8%
Boot Barn Holdings, Inc. BOOT$3.9 billion15.8618.3%13.8%16.8%0.00n/a
Asbury Automotive Group Inc. ABG$3.6 billion8.0811.6%4.2%-1.3%0.84n/a
American Eagle Outfitters Inc. AEO$3.3 billion10.1619.1%7.8%9.2%0.032.5%
Pattern Group Inc. PTRN$3.2 billion28.1217.8%4.3%n/a0.00n/a
Group 1 Automotive Inc. GPI$3.1 billion8.2712.4%3.6%-3.4%1.960.8%
Advance Auto Parts Inc. AAP$2.7 billion27.774.4%3.0%-0.3%1.502.2%
Guardian Pharmacy Services, Inc. GRDN$2.7 billion36.2726.7%6.5%4.9%0.00n/a
Kohl's Corp. KSS$2.6 billion10.056.5%3.8%-2.9%0.322.2%
Bob's Discount Furniture, Inc. BOBS$2.5 billion17.4124.9%8.4%n/a0.00n/a
RH RH$2.5 billion23.2992.7%10.0%3.3%19.69n/a
Buckle Inc. BKE$2.2 billion9.6745.2%20.8%6.2%0.003.3%
Arhaus, Inc. ARHS$2.0 billion30.8315.2%6.1%5.2%0.00n/a
Sonic Automotive Inc. SAH$2.0 billion9.9319.4%3.2%2.0%1.652.5%
Weis Markets Inc. WMK$1.9 billion18.587.5%2.6%4.3%0.001.7%
Ezcorp Inc. EZPW$1.8 billion14.4113.6%13.9%28.6%0.45n/a
Sally Beauty Holdings, Inc. SBH$1.7 billion9.5322.1%8.4%1.1%0.94n/a
TheRealReal, Inc. REAL$1.6 billionn/an/a0.4%18.1%n/an/a
Ingles Markets Inc. IMKTA$1.6 billion15.036.2%2.6%1.0%0.30n/a
Savers Value Village, Inc. SVV$1.5 billion24.5713.2%8.1%10.1%1.41n/a
Revolve Group, Inc. RVLV$1.3 billion20.1311.8%5.6%14.7%0.00n/a
Grocery Outlet Holding Corp. GO$1.3 billionn/a-46.7%-7.9%5.1%0.62n/a
Marinemax Inc. HZO$1.2 billion376.460.4%3.0%-5.4%1.02n/a
Suburban Propane Partners LP SPH$1.1 billion8.77n/a15.1%-2.5%n/an/a
Petco Health & Wellness Company, Inc. WOOF$956 million29.502.5%2.2%-1.3%1.22n/a
Winmark Corp. WINA$943 million23.63n/a59.7%8.6%n/an/a
Krispy Kreme, Inc. DNUT$721 millionn/a-13.7%-2.2%-7.5%1.410.8%
Natural Grocers by Vitamin Cottage, Inc. NGVC$661 million13.9319.9%4.7%2.0%0.012.0%
Honest Company, Inc. HNST$544 million6.7529.8%-4.2%-12.8%0.00n/a
Titan Machinery Inc. TITN$523 millionn/a-10.2%-0.4%-10.7%1.43n/a
Camping World Holdings, Inc. CWH$474 millionn/a-499.8%-3.5%-5.5%52.72n/a
Arko Corp. ARKO$445 million79.302.9%1.2%5.9%1.51n/a
Barnes & Noble Education, Inc. BNED$437 million19.648.0%2.5%5.0%0.44n/a
Star Group, L.P. SGU$433 millionn/an/a7.1%7.6%n/an/a
Shoe Station Group Inc. SHOE$395 million16.523.6%2.8%-4.1%0.004.4%
Genesco Inc. GCO$390 million9.397.4%2.0%3.0%0.03n/a
Nextnrg, Inc. NXXT$383 millionn/an/a-50.9%90.3%n/an/a
Citi Trends Inc. CTRN$375 million54.885.9%0.6%11.1%0.00n/a
Build-A-Bear Workshop Inc. BBW$370 million7.37n/an/a-0.9%0.002.8%
Stitch Fix, Inc. SFIX$365 millionn/a-6.4%-1.6%6.4%0.00n/a
Lands' End, Inc. LE$279 million0.8371.3%0.5%0.4%0.12n/a
Envela Corp. ELA$278 million12.6127.9%9.6%47.7%0.12n/a
Lovesac Co. LOVE$228 million12.938.5%3.3%1.1%0.00n/a
Zumiez Inc. ZUMZ$223 million19.564.6%2.2%3.6%0.00n/a
Torrid Holdings Inc. CURV$216 millionn/an/a1.9%-11.2%n/an/a
1stdibs.com, Inc. DIBS$205 millionn/a-7.4%-10.8%2.6%0.00n/a
ThredUp Inc. TDUP$171 millionn/a-38.8%-7.2%14.1%0.29n/a
Neighborhood Intelligence, Inc. NXH$166 millionn/a-35.2%-9.8%29.5%0.73n/a
1 800 Flowers COM Inc. FLWS$165 millionn/a-146.6%-8.4%-10.8%2.88n/a
Vince Holding Corp. VNCE$164 million22.2313.0%4.3%8.0%0.21n/a
A.K.A. Brands Holding Corp. AKA$110 millionn/a-32.7%-2.9%3.8%1.13n/a
GrowGeneration Corp. GRWG$91 millionn/a-18.7%-10.8%1.6%0.00n/a
Bark, Inc. BARK$83 millionn/a-33.8%-7.5%-22.2%0.00n/a
Rent the Runway, Inc. RENT$74 million0.17n/a-12.3%21.2%n/an/a
Host Digital Inc. HOST$63 millionn/a-274.8%-8.7%-7.3%1.35n/a
1 company shares its SEC industry code (Retail-Drug Stores And Proprietary Stores); the rest are the names nearest in size in its wider industry, Retail, one of the Fama-French 48 industries, a published grouping of SEC industry codes.
Read moreBy market capitalisation; a click on a heading sorts by it, largest first, and a second click turns it round. Each figure is the same arithmetic as the ratio box above, on each company's own filings and latest close; a name marked * is a foreign company that files once a year, on its latest fiscal year.

The public record on CVS

Dividends$2.66 a share over the four quarters to 30 September 2026, a 3.17% yield
Filings20 in twelve months: 10 current reports (8-K), about 4 results of operations; 3 regulation FD disclosure; 3 officer or director change; 1 shareholder vote; 1 other events
Planned insider sales3 Form 144 notices in twelve months, $6.7 million; latest 22 May 2026
Options tapeput/call 1.03 by open interest at the 6 November 2026 close; the straddle prices a 3.9% move to 13 November 2026
13F holders2,084 funds reported a position for the quarter to 30 June 2026; largest BlackRock, Inc.
Insider trading8 sales and 2 purchases on Form 4 in twelve months
Congress1 House trade disclosed in six months
Short interest16.2 million shares short, 1.57 days to cover at 15 October 2026
Documentsthe 10-K, the 10-Qs, the proxy and 4 earnings press releases, each linked

Filings

FilingPeriodFiledWhere
10-Q30 September 20264 November 2026EDGAR
10-Q30 June 20265 August 2026EDGAR
10-Q31 March 20266 May 2026EDGAR
10-K31 December 202510 February 2026EDGAR
10-Q30 September 202529 October 2025EDGAR
10-Q30 June 202531 July 2025EDGAR
10-Q31 March 20251 May 2025EDGAR
10-K31 December 202412 February 2025EDGAR
10-Q30 September 20246 November 2024EDGAR
10-Q30 June 20247 August 2024EDGAR

Reading about a stock somewhere else? Our free Chrome extension, GreekSoup Stock Ticker Lookup: Earnings, Insider Trades, 13F Holders, shows the latest quarter against a year ago, insider trades and 13F holders when you hover a $ticker such as $AAPL.